Perindopril Erbumine API
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Rivaroxaban API Market Research Report 2024
1 Rivaroxaban API Market Overview
1.1 Product Overview and Scope of Rivaroxaban API
1.2 Rivaroxaban API Segment by Type
1.2.1 Global Rivaroxaban API Market Size Growth Rate Analysis by Type 2021 VS 2027
1.2.2 Purity≥98%
1.2.3 Purity<98%
1.3 Rivaroxaban API Segment by Application
1.3.1 Global Rivaroxaban API Consumption Comparison by Application: 2016 VS 2021 VS 2027
1.3.2 Rivaroxaban Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Rivaroxaban API Revenue Estimates and Forecasts (2016-2027)
1.4.2 Global Rivaroxaban API Production Capacity Estimates and Forecasts (2016-2027)
1.4.3 Global Rivaroxaban API Production Estimates and Forecasts (2016-2027)
1.5 Global Market Size by Region
1.5.1 Global Rivaroxaban API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
1.5.2 North America Rivaroxaban API Estimates and Forecasts (2016-2027)
1.5.3 Europe Rivaroxaban API Estimates and Forecasts (2016-2027)
1.5.4 China Rivaroxaban API Estimates and Forecasts (2016-2027)
1.5.5 China Taiwan Rivaroxaban API Estimates and Forecasts (2016-2027)
1.5.6 India Rivaroxaban API Estimates and Forecasts (2016-2027)
1.5.7 Israel Rivaroxaban API Estimates and Forecasts (2016-2027)
2 Market Competition by Manufacturers
2.1 Global Rivaroxaban API Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Rivaroxaban API Revenue Market Share by Manufacturers (2016-2021)
2.3 Rivaroxaban API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Rivaroxaban API Average Price by Manufacturers (2016-2021)
2.5 Manufacturers Rivaroxaban API Production Sites, Area Served, Product Types
2.6 Rivaroxaban API Market Competitive Situation and Trends
2.6.1 Rivaroxaban API Market Concentration Rate
2.6.2 Global 5 and 10 Largest Rivaroxaban API Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production and Capacity by Region
3.1 Global Production Capacity of Rivaroxaban API Market Share by Region (2016-2021)
3.2 Global Rivaroxaban API Revenue Market Share by Region (2016-2021)
3.3 Global Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 North America Rivaroxaban API Production
3.4.1 North America Rivaroxaban API Production Growth Rate (2016-2021)
3.4.2 North America Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Rivaroxaban API Production
3.5.1 Europe Rivaroxaban API Production Growth Rate (2016-2021)
3.5.2 Europe Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 China Rivaroxaban API Production
3.6.1 China Rivaroxaban API Production Growth Rate (2016-2021)
3.6.2 China Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 China Taiwan Rivaroxaban API Production
3.7.1 China Taiwan Rivaroxaban API Production Growth Rate (2016-2021)
3.7.2 China Taiwan Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 India Rivaroxaban API Production
3.8.1 India Rivaroxaban API Production Growth Rate (2016-2021)
3.8.2 India Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Israel Rivaroxaban API Production
3.9.1 Israel Rivaroxaban API Production Growth Rate (2016-2021)
3.9.2 Israel Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Rivaroxaban API Consumption by Region
4.1 Global Rivaroxaban API Consumption by Region
4.1.1 Global Rivaroxaban API Consumption by Region
4.1.2 Global Rivaroxaban API Consumption Market Share by Region
4.2 North America
4.2.1 North America Rivaroxaban API Consumption by Country
4.2.2 United States
4.2.3 Canada
4.3 Europe
4.3.1 Europe Rivaroxaban API Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Rivaroxaban API Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Rivaroxaban API Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Rivaroxaban API Production Market Share by Type (2016-2021)
5.2 Global Rivaroxaban API Revenue Market Share by Type (2016-2021)
5.3 Global Rivaroxaban API Price by Type (2016-2021)
6 Consumption Analysis by Application
6.1 Global Rivaroxaban API Consumption Market Share by Application (2016-2021)
6.2 Global Rivaroxaban API Consumption Growth Rate by Application (2016-2021)
7 Key Companies Profiled
7.1 Piramal Enterprises Limited
7.1.1 Piramal Enterprises Limited Rivaroxaban API Corporation Information
7.1.2 Piramal Enterprises Limited Rivaroxaban API Product Portfolio
7.1.3 Piramal Enterprises Limited Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.1.4 Piramal Enterprises Limited Main Business and Markets Served
7.1.5 Piramal Enterprises Limited Recent Developments/Updates
7.2 Dr. Reddy's Laboratories
7.2.1 Dr. Reddy's Laboratories Rivaroxaban API Corporation Information
7.2.2 Dr. Reddy's Laboratories Rivaroxaban API Product Portfolio
7.2.3 Dr. Reddy's Laboratories Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.2.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.3 Polpharma S. A.
7.3.1 Polpharma S. A. Rivaroxaban API Corporation Information
7.3.2 Polpharma S. A. Rivaroxaban API Product Portfolio
7.3.3 Polpharma S. A. Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.3.4 Polpharma S. A. Main Business and Markets Served
7.3.5 Polpharma S. A. Recent Developments/Updates
7.4 ZCL Chemicals Limited
7.4.1 ZCL Chemicals Limited Rivaroxaban API Corporation Information
7.4.2 ZCL Chemicals Limited Rivaroxaban API Product Portfolio
7.4.3 ZCL Chemicals Limited Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.4.4 ZCL Chemicals Limited Main Business and Markets Served
7.4.5 ZCL Chemicals Limited Recent Developments/Updates
7.5 Interquim SA
7.5.1 Interquim SA Rivaroxaban API Corporation Information
7.5.2 Interquim SA Rivaroxaban API Product Portfolio
7.5.3 Interquim SA Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.5.4 Interquim SA Main Business and Markets Served
7.5.5 Interquim SA Recent Developments/Updates
7.6 Medichem S.A
7.6.1 Medichem S.A Rivaroxaban API Corporation Information
7.6.2 Medichem S.A Rivaroxaban API Product Portfolio
7.6.3 Medichem S.A Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.6.4 Medichem S.A Main Business and Markets Served
7.6.5 Medichem S.A Recent Developments/Updates
7.7 UQUIFA
7.7.1 UQUIFA Rivaroxaban API Corporation Information
7.7.2 UQUIFA Rivaroxaban API Product Portfolio
7.7.3 UQUIFA Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.7.4 UQUIFA Main Business and Markets Served
7.7.5 UQUIFA Recent Developments/Updates
7.8 Inke
7.8.1 Inke Rivaroxaban API Corporation Information
7.8.2 Inke Rivaroxaban API Product Portfolio
7.8.3 Inke Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.8.4 Inke Main Business and Markets Served
7.7.5 Inke Recent Developments/Updates
7.9 Tecoland
7.9.1 Tecoland Rivaroxaban API Corporation Information
7.9.2 Tecoland Rivaroxaban API Product Portfolio
7.9.3 Tecoland Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.9.4 Tecoland Main Business and Markets Served
7.9.5 Tecoland Recent Developments/Updates
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Corporation Information
7.10.2 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Product Portfolio
7.10.3 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.10.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
7.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.11 Symed Labs Limited
7.11.1 Symed Labs Limited Rivaroxaban API Corporation Information
7.11.2 Symed Labs Limited Rivaroxaban API Product Portfolio
7.11.3 Symed Labs Limited Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.11.4 Symed Labs Limited Main Business and Markets Served
7.11.5 Symed Labs Limited Recent Developments/Updates
7.12 Unichem Laboratories Limited
7.12.1 Unichem Laboratories Limited Rivaroxaban API Corporation Information
7.12.2 Unichem Laboratories Limited Rivaroxaban API Product Portfolio
7.12.3 Unichem Laboratories Limited Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.12.4 Unichem Laboratories Limited Main Business and Markets Served
7.12.5 Unichem Laboratories Limited Recent Developments/Updates
7.13 Lupin Ltd
7.13.1 Lupin Ltd Rivaroxaban API Corporation Information
7.13.2 Lupin Ltd Rivaroxaban API Product Portfolio
7.13.3 Lupin Ltd Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.13.4 Lupin Ltd Main Business and Markets Served
7.13.5 Lupin Ltd Recent Developments/Updates
7.14 Neuland Laboratories
7.14.1 Neuland Laboratories Rivaroxaban API Corporation Information
7.14.2 Neuland Laboratories Rivaroxaban API Product Portfolio
7.14.3 Neuland Laboratories Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.14.4 Neuland Laboratories Main Business and Markets Served
7.14.5 Neuland Laboratories Recent Developments/Updates
7.15 NG ZIP CHEMICAL INDUSTRIAL
7.15.1 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Corporation Information
7.15.2 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Product Portfolio
7.15.3 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.15.4 NG ZIP CHEMICAL INDUSTRIAL Main Business and Markets Served
7.15.5 NG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
7.16 Zhejiang Huahai Pharmaceutial. Co., Ltd.
7.16.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Corporation Information
7.16.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Product Portfolio
7.16.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.16.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
7.16.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
7.17 Glenmark Pharmaceuticals
7.17.1 Glenmark Pharmaceuticals Rivaroxaban API Corporation Information
7.17.2 Glenmark Pharmaceuticals Rivaroxaban API Product Portfolio
7.17.3 Glenmark Pharmaceuticals Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.17.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.17.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.18 Srini Pharmaceuticals Private Limited
7.18.1 Srini Pharmaceuticals Private Limited Rivaroxaban API Corporation Information
7.18.2 Srini Pharmaceuticals Private Limited Rivaroxaban API Product Portfolio
7.18.3 Srini Pharmaceuticals Private Limited Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.18.4 Srini Pharmaceuticals Private Limited Main Business and Markets Served
7.18.5 Srini Pharmaceuticals Private Limited Recent Developments/Updates
7.19 Jiangxi Synergy Pharmaceutical Co., Ltd
7.19.1 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Corporation Information
7.19.2 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Product Portfolio
7.19.3 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.19.4 Jiangxi Synergy Pharmaceutical Co., Ltd Main Business and Markets Served
7.19.5 Jiangxi Synergy Pharmaceutical Co., Ltd Recent Developments/Updates
7.20 Lunan Pharmaceutical Group
7.20.1 Lunan Pharmaceutical Group Rivaroxaban API Corporation Information
7.20.2 Lunan Pharmaceutical Group Rivaroxaban API Product Portfolio
7.20.3 Lunan Pharmaceutical Group Rivaroxaban API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.20.4 Lunan Pharmaceutical Group Main Business and Markets Served
7.20.5 Lunan Pharmaceutical Group Recent Developments/Updates
8 Rivaroxaban API Manufacturing Cost Analysis
8.1 Rivaroxaban API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Rivaroxaban API
8.4 Rivaroxaban API Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Rivaroxaban API Distributors List
9.3 Rivaroxaban API Customers
10 Market Dynamics
10.1 Rivaroxaban API Industry Trends
10.2 Rivaroxaban API Growth Drivers
10.3 Rivaroxaban API Market Challenges
10.4 Rivaroxaban API Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Rivaroxaban API by Region (2022-2027)
11.2 North America Rivaroxaban API Production, Revenue Forecast (2022-2027)
11.3 Europe Rivaroxaban API Production, Revenue Forecast (2022-2027)
11.4 China Rivaroxaban API Production, Revenue Forecast (2022-2027)
11.5 China Taiwan Rivaroxaban API Production, Revenue Forecast (2022-2027)
11.6 India Rivaroxaban API Production, Revenue Forecast (2022-2027)
11.7 Israel Rivaroxaban API Production, Revenue Forecast (2022-2027)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Rivaroxaban API
12.2 North America Forecasted Consumption of Rivaroxaban API by Country
12.3 Europe Market Forecasted Consumption of Rivaroxaban API by Country
12.4 Asia Pacific Market Forecasted Consumption of Rivaroxaban API by Region
12.5 Latin America Forecasted Consumption of Rivaroxaban API by Country
13 Forecast by Type and by Application (2022-2027)
13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
13.1.1 Global Forecasted Production of Rivaroxaban API by Type (2022-2027)
13.1.2 Global Forecasted Revenue of Rivaroxaban API by Type (2022-2027)
13.1.3 Global Forecasted Price of Rivaroxaban API by Type (2022-2027)
13.2 Global Forecasted Consumption of Rivaroxaban API by Application (2022-2027)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Rivaroxaban API Market Size by Type (Ton) & (US$ Million) (2021 VS 2027)
Table 2. Global Rivaroxaban API Consumption (Ton) Comparison by Application: 2016 VS 2021 VS 2027
Table 3. Rivaroxaban API Market Size Comparison by Region: 2016 VS 2021 VS 2027
Table 4. Global Rivaroxaban API Production Capacity (Ton) by Manufacturers
Table 5. Global Rivaroxaban API Production (Ton) by Manufacturers (2016-2021)
Table 6. Global Rivaroxaban API Production Market Share by Manufacturers (2016-2021)
Table 7. Global Rivaroxaban API Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Rivaroxaban API Revenue Share by Manufacturers (2016-2021)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rivaroxaban API as of 2020)
Table 10. Global Market Rivaroxaban API Average Price (US$/Ton) of Key Manufacturers (2016-2021)
Table 11. Manufacturers Rivaroxaban API Production Sites and Area Served
Table 12. Manufacturers Rivaroxaban API Product Types
Table 13. Mergers & Acquisitions, Expansion
Table 14. Global Rivaroxaban API Production Capacity (Ton) by Region (2016-2021)
Table 15. Global Rivaroxaban API Production (Ton) by Region (2016-2021)
Table 16. Global Rivaroxaban API Revenue (US$ Million) by Region (2016-2021)
Table 17. Global Rivaroxaban API Revenue Market Share by Region (2016-2021)
Table 18. Global Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 19. North America Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 20. Europe Rivaroxaban API Production (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 21. China Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 22. China Taiwan Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 23. India Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 24. Israel Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 25. Global Rivaroxaban API Consumption Market by Region (2016-2021) & (Ton)
Table 26. Global Rivaroxaban API Consumption Market Share by Region (2016-2021)
Table 27. North America Rivaroxaban API Consumption by Country (2016-2021) & (Ton)
Table 28. Europe Rivaroxaban API Consumption by Country (2016-2021) & (Ton)
Table 29. Asia Pacific Rivaroxaban API Consumption by Region (2016-2021) & (Ton)
Table 30. Latin America Rivaroxaban API Consumption by Countries (2016-2021) & (Ton)
Table 31. Global Rivaroxaban API Production (Ton) by Type (2016-2021)
Table 32. Global Rivaroxaban API Production Market Share by Type (2016-2021)
Table 33. Global Rivaroxaban API Revenue (US$ Million) by Type (2016-2021)
Table 34. Global Rivaroxaban API Revenue Share by Type (2016-2021)
Table 35. Global Rivaroxaban API Price (US$/Ton) by Type (2016-2021)
Table 36. Global Rivaroxaban API Consumption by Application (2016-2021) & (Ton)
Table 37. Global Rivaroxaban API Consumption Market Share by Application (2016-2021)
Table 38. Global Rivaroxaban API Consumption Growth Rate by Application (2016-2021)
Table 39. Piramal Enterprises Limited Rivaroxaban API Corporation Information
Table 40. Piramal Enterprises Limited Specification and Application
Table 41. Piramal Enterprises Limited Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 42. Piramal Enterprises Limited Main Business and Markets Served
Table 43. Piramal Enterprises Limited Recent Developments/Updates
Table 44. Dr. Reddy's Laboratories Rivaroxaban API Corporation Information
Table 45. Dr. Reddy's Laboratories Specification and Application
Table 46. Dr. Reddy's Laboratories Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 47. Dr. Reddy's Laboratories Main Business and Markets Served
Table 48. Dr. Reddy's Laboratories Recent Developments/Updates
Table 49. Polpharma S. A. Rivaroxaban API Corporation Information
Table 50. Polpharma S. A. Specification and Application
Table 51. Polpharma S. A. Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 52. Polpharma S. A. Main Business and Markets Served
Table 53. Polpharma S. A. Recent Developments/Updates
Table 54. ZCL Chemicals Limited Rivaroxaban API Corporation Information
Table 55. ZCL Chemicals Limited Specification and Application
Table 56. ZCL Chemicals Limited Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 57. ZCL Chemicals Limited Main Business and Markets Served
Table 58. ZCL Chemicals Limited Recent Developments/Updates
Table 59. Interquim SA Rivaroxaban API Corporation Information
Table 60. Interquim SA Specification and Application
Table 61. Interquim SA Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 62. Interquim SA Main Business and Markets Served
Table 63. Interquim SA Recent Developments/Updates
Table 64. Medichem S.A Rivaroxaban API Corporation Information
Table 65. Medichem S.A Specification and Application
Table 66. Medichem S.A Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 67. Medichem S.A Main Business and Markets Served
Table 68. Medichem S.A Recent Developments/Updates
Table 69. UQUIFA Rivaroxaban API Corporation Information
Table 70. UQUIFA Specification and Application
Table 71. UQUIFA Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 72. UQUIFA Main Business and Markets Served
Table 73. UQUIFA Recent Developments/Updates
Table 74. Inke Rivaroxaban API Corporation Information
Table 75. Inke Specification and Application
Table 76. Inke Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 77. Inke Main Business and Markets Served
Table 78. Inke Recent Developments/Updates
Table 79. Tecoland Rivaroxaban API Corporation Information
Table 80. Tecoland Specification and Application
Table 81. Tecoland Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 82. Tecoland Main Business and Markets Served
Table 83. Tecoland Recent Developments/Updates
Table 84. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Corporation Information
Table 85. Teva Pharmaceutical Industries Ltd. Specification and Application
Table 86. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 87. Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
Table 88. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 89. Symed Labs Limited Rivaroxaban API Corporation Information
Table 90. Symed Labs Limited Specification and Application
Table 91. Symed Labs Limited Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 92. Symed Labs Limited Main Business and Markets Served
Table 93. Symed Labs Limited Recent Developments/Updates
Table 94. Unichem Laboratories Limited Rivaroxaban API Corporation Information
Table 95. Unichem Laboratories Limited Specification and Application
Table 96. Unichem Laboratories Limited Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 97. Unichem Laboratories Limited Main Business and Markets Served
Table 98. Unichem Laboratories Limited Recent Developments/Updates
Table 99. Lupin Ltd Rivaroxaban API Corporation Information
Table 100. Lupin Ltd Specification and Application
Table 101. Lupin Ltd Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 102. Lupin Ltd Main Business and Markets Served
Table 103. Lupin Ltd Recent Developments/Updates
Table 104. Neuland Laboratories Rivaroxaban API Corporation Information
Table 105. Neuland Laboratories Specification and Application
Table 106. Neuland Laboratories Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 107. Neuland Laboratories Main Business and Markets Served
Table 108. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 109. Neuland Laboratories Rivaroxaban API Corporation Information
Table 110. NG ZIP CHEMICAL INDUSTRIAL Specification and Application
Table 111. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 112. NG ZIP CHEMICAL INDUSTRIAL Main Business and Markets Served
Table 113. NG ZIP CHEMICAL INDUSTRIAL Recent Developments/Updates
Table 114. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Corporation Information
Table 115. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 116. Zhejiang Huahai Pharmaceutial. Co., Ltd. Main Business and Markets Served
Table 117. Zhejiang Huahai Pharmaceutial. Co., Ltd. Recent Developments/Updates
Table 118. Glenmark Pharmaceuticals Rivaroxaban API Corporation Information
Table 119. Glenmark Pharmaceuticals Specification and Application
Table 120. Glenmark Pharmaceuticals Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 121. Glenmark Pharmaceuticals Main Business and Markets Served
Table 122. Glenmark Pharmaceuticals Recent Developments/Updates
Table 123. Srini Pharmaceuticals Private Limited Rivaroxaban API Corporation Information
Table 124. Srini Pharmaceuticals Private Limited Specification and Application
Table 125. Srini Pharmaceuticals Private Limited Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 126. Srini Pharmaceuticals Private Limited Main Business and Markets Served
Table 127. Srini Pharmaceuticals Private Limited Recent Developments/Updates
Table 128. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Corporation Information
Table 129. Jiangxi Synergy Pharmaceutical Co., Ltd Specification and Application
Table 130. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 131. Jiangxi Synergy Pharmaceutical Co., Ltd Main Business and Markets Served
Table 132. Jiangxi Synergy Pharmaceutical Co., Ltd Recent Developments/Updates
Table 133. Lunan Pharmaceutical Group Rivaroxaban API Corporation Information
Table 134. Lunan Pharmaceutical Group Specification and Application
Table 135. Lunan Pharmaceutical Group Rivaroxaban API Production Capacity (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 136. Lunan Pharmaceutical Group Main Business and Markets Served
Table 137. Lunan Pharmaceutical Group Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Rivaroxaban API Distributors List
Table 141. Rivaroxaban API Customers List
Table 142. Rivaroxaban API Market Trends
Table 143. Rivaroxaban API Growth Drivers
Table 144. Rivaroxaban API Market Challenges
Table 145. Rivaroxaban API Market Restraints
Table 146. Global Rivaroxaban API Production (Ton) Forecast by Region (2022-2027)
Table 147. North America Rivaroxaban API Consumption Forecast by Country (2022-2027) & (Ton)
Table 148. Europe Rivaroxaban API Consumption Forecast by Country (2022-2027) & (Ton)
Table 149. Asia Pacific Rivaroxaban API Consumption Forecast by Region (2022-2027) & (Ton)
Table 150. Latin America Rivaroxaban API Consumption Forecast by Country (2022-2027) & (Ton)
Table 151. Global Rivaroxaban API Production Forecast by Type (2022-2027) & (Ton)
Table 152. Global Rivaroxaban API Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global Rivaroxaban API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 154. Global Rivaroxaban API Consumption (Ton) Forecast by Application (2022-2027)
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Rivaroxaban API
Figure 2. Global Rivaroxaban API Market Share by Type: 2020 VS 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Rivaroxaban API Market Share by Application: 2020 VS 2027
Figure 6. Rivaroxaban Tablets
Figure 7. Others
Figure 8. Global Rivaroxaban API Revenue (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Rivaroxaban API Revenue (US$ Million) (2016-2027)
Figure 10. Global Rivaroxaban API Production Capacity (Ton) & (2016-2027)
Figure 11. Global Rivaroxaban API Production (Ton) & (2016-2027)
Figure 12. North America Rivaroxaban API Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 13. Europe Rivaroxaban API Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 14. China Rivaroxaban API Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 15. China Taiwan Rivaroxaban API Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 16. India Rivaroxaban API Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 17. Israel Rivaroxaban API Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 18. Rivaroxaban API Production Share by Manufacturers in 2020
Figure 19. Global Rivaroxaban API Revenue Share by Manufacturers in 2020
Figure 20. Rivaroxaban API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Market Rivaroxaban API Average Price (US$/Ton) of Key Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest Players: Market Share by Rivaroxaban API Revenue in 2020
Figure 23. Global Rivaroxaban API Production Market Share by Region (2016-2021)
Figure 24. North America Rivaroxaban API Production (Ton) Growth Rate (2016-2021)
Figure 25. Europe Rivaroxaban API Production (Ton) Growth Rate (2016-2021)
Figure 26. China Rivaroxaban API Production (Ton) Growth Rate (2016-2021)
Figure 27. China Taiwan Rivaroxaban API Production (Ton) Growth Rate (2016-2021)
Figure 28. India Rivaroxaban API Production (Ton) Growth Rate (2016-2021)
Figure 29. Israel Rivaroxaban API Production (Ton) Growth Rate (2016-2021)
Figure 30. Global Rivaroxaban API Consumption Market Share by Region (2016-2021)
Figure 31. Global Rivaroxaban API Consumption Market Share by Region in 2020
Figure 32. North America Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 33. North America Rivaroxaban API Consumption Market Share by Country in 2020
Figure 34. Canada Rivaroxaban API Consumption Growth Rate (2016-2021) & (Ton)
Figure 35. U.S. Rivaroxaban API Consumption Growth Rate (2016-2021) & (Ton)
Figure 36. Europe Rivaroxaban API Consumption Growth Rate (2016-2021) & (Ton)
Figure 37. Europe Rivaroxaban API Consumption Market Share by Country in 2020
Figure 38. Germany America Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 39. France Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 40. U.K. Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 41. Italy Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 42. Russia Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 43. Asia Pacific Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 44. Asia Pacific Rivaroxaban API Consumption Market Share by Regions in 2020
Figure 45. China Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 46. Japan Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 47. South Korea Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 48. Taiwan Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 49. Southeast Asia Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 50. India Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 51. Australia Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 52. Latin America Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 53. Latin America Rivaroxaban API Consumption Market Share by Country in 2020
Figure 54. Mexico Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 55. Brazil Rivaroxaban API Consumption and Growth Rate (2016-2021) & (Ton)
Figure 56. Production Market Share of Rivaroxaban API by Type (2016-2021)
Figure 57. Production Market Share of Rivaroxaban API by Type in 2020
Figure 58. Revenue Share of Rivaroxaban API by Type (2016-2021)
Figure 59. Revenue Market Share of Rivaroxaban API by Type in 2020
Figure 60. Global Rivaroxaban API Consumption Market Share by Application (2016-2021)
Figure 61. Global Rivaroxaban API Consumption Market Share by Application in 2020
Figure 62. Global Rivaroxaban API Consumption Growth Rate by Application (2016-2021)
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Rivaroxaban API
Figure 65. Manufacturing Process Analysis of Rivaroxaban API
Figure 66. Rivaroxaban API Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Global Rivaroxaban API Production Market Share Forecast by Region (2022-2027)
Figure 70. North America Rivaroxaban API Production (Ton) Growth Rate Forecast (2022-2027)
Figure 71. Europe Rivaroxaban API Production (Ton) Growth Rate Forecast (2022-2027)
Figure 72. China Rivaroxaban API Production (Ton) Growth Rate Forecast (2022-2027)
Figure 73. China Taiwan Rivaroxaban API Production (Ton) Growth Rate Forecast (2022-2027)
Figure 74. India Rivaroxaban API Production (Ton) Growth Rate Forecast (2022-2027)
Figure 75. Israel Rivaroxaban API Production (Ton) Growth Rate Forecast (2022-2027)
Figure 76. Global Forecasted Demand Analysis of Rivaroxaban API (2015-2027) & (Ton)
Figure 77. Global Rivaroxaban API Production Market Share Forecast by Type (2022-2027)
Figure 78. Global Rivaroxaban API Revenue Market Share Forecast by Type (2022-2027)
Figure 79. Global Rivaroxaban API Consumption Forecast by Application (2022-2027)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Piramal Enterprises Limited Dr. Reddy's Laboratories Polpharma S. A. ZCL Chemicals Limited Interquim SA Medichem S.A UQUIFA Inke Tecoland Teva Pharmaceutical Industries Ltd. Symed Labs Limited Unichem Laboratories Limited Lupin Ltd Neuland Laboratories NG ZIP CHEMICAL INDUSTRIAL Zhejiang Huahai Pharmaceutial. Co., Ltd. Glenmark Pharmaceuticals Srini Pharmaceuticals Private Limited Jiangxi Synergy Pharmaceutical Co., Ltd Lunan Pharmaceutical Group